Cisplatin (Cis)/etoposide (VP16) compared to cis/irinotecan (CPT11) in extensive-stage small cell lung cancer (E-SCLC): Pharmacogenomic (PG) and comparative toxicity analysis of JCOG 9511 and SWOG 0124
暂无分享,去创建一个
N. Saijo | D. Gandara | H. Lenz | P. Lara | T. Tamura | M. Gordon | R. Natale | T. Shibata | M. Redman | H. Fukuda | P. Lara | D. R. Gandara